For genes coding for phase II xenobiotics metabolizing enzymes, the deletion of GSTT1 and GSTM1 were reported by Khedhaier (114) to predict the early onset and prognosis of breast cancer among Tunisian women. Here, GSTM1 is linked to breast carcinoma.